The Journal of Experimental Medicine
StemCell Technologies
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 17 October 2005. doi:10.1084/jem2028iti3
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 202, Number 8, 1015-1015
This Article
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Epps, H. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Van Epps, H. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

IN THIS ISSUE

FoxP3 gets a new gig

FoxP3 (red) is expressed on cortical epithelial cells (green) and drives thymocyte proliferation.

On page 1141, the one-trick transcription factor FoxP3 reveals a new function. According to Chang and colleagues, FoxP3 does more than just drive regulatory T (T reg) cell development; it also promotes the proliferation of developing thymocytes.

FoxP3 is required for the development of CD4+CD25+ T reg cells, which subdue the activation of conventional T cells and thus protect against chronic inflammation and autoimmunity. Mice and humans that lack FoxP3 develop a spontaneous, multi-organ autoimmune disease that has been primarily attributed to the lack of T reg cells. But one fact suggests that this explanation may be too simple. Irradiated mice that are reconstituted with FoxP3-deficient bone marrow do not develop disease, suggesting that FoxP3 also functions in nonhematopoietic cells.

Chang and colleagues now show that FoxP3 is not exclusive to T cells, but is also expressed in thymic epithelial cells. In mice lacking FoxP3, developing thymocytes were unable to proliferate normally, resulting in thymic atrophy. The proliferation defect was caused by a lack of FoxP3 in thymic stromal cells, rather than in T cells, as normal thymocytes also failed to proliferate in a FoxP3-deficient thymic environment.How FoxP3 expression on thymic epithelial cells helps drive thymocyte proliferation is unknown. Also unclear is how the proliferation defect contributes to autoimmune disease, although there is a long-standing but poorly understood link between thymic atrophy and T cell–driven autoimmune disease. {JEMiti_end}



Heather L. Van Epps

hvanepps{at}rockefeller.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Epps, H. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Van Epps, H. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS